Engagements

Medical device company restructuring

CRA was engaged by a market leading medical device company to assist with a business restructuring to consolidate its IP ownership within the group structure and re-align its supply chains.

Related capabilities

Life Sciences Transfer Pricing & Tax Disputes
Transfer Pricing

Transfer Pricing
CRA News

Medtronic v. Commissioner: Rebel Curd and Robin Hart interviewed by Law360 Tax Authority

Rebel Curd, Robin Hart, and two tax lawyers were interviewed for an October 14, 2022 Law360 Tax Authority article about an unspecified transfer pricing method...
Transfer Pricing
CRA Insights

US Tax Court favors unspecified method to determine royalty rate

The first US transfer pricing court decision of 2022 was published on Thursday, August 18, 2022, specifically Medtronic, Inc. and Consolidated Subsidiaries v....

Explore our thinking

Medical device company restructuring

Related insights

Medtronic v. Commissioner: Rebel Curd and Robin Hart interviewed by Law360 Tax Authority

US Tax Court favors unspecified method to determine royalty rate